Transcription Factor FIGLA is Mutated in Patients with Premature Ovarian Failure
Han Zhao,Zi-Jiang Chen,Yingying Qin,Yuhua Shi,Shan Wang,Youngsok Choi,Joe Leigh Simpson,Aleksandar Rajkovic
DOI: https://doi.org/10.1016/j.ajhg.2008.04.018
2008-01-01
The American Journal of Human Genetics
Abstract:Premature Ovarian Failure (POF) is a genetically heterogenous disorder that leads to hypergonadotropic ovarian failure and infertility. We screened 100 Chinese women with POF for mutations in the oocyte-specific gene FIGLA and identified three variants in four women: missense mutation c.11C → A (p.A4E) was found in two women; deletion c. 15–36 del (p.G6fsX66), resulting in a frameshift that leads to haploinsufficiency, was found in one woman; and deletion c.419–421 delACA (p.140 delN) was found in one. Functional analyses by the yeast two-hybrid assay demonstrated that the p.140 delN mutation disrupted FIGLA binding to the TCF3 helix-loop-helix (HLH) domain. Our findings show that a subset of Chinese women with sporadic, premature ovarian failure harbor mutations in FIGLA. Premature Ovarian Failure (POF) is a genetically heterogenous disorder that leads to hypergonadotropic ovarian failure and infertility. We screened 100 Chinese women with POF for mutations in the oocyte-specific gene FIGLA and identified three variants in four women: missense mutation c.11C → A (p.A4E) was found in two women; deletion c. 15–36 del (p.G6fsX66), resulting in a frameshift that leads to haploinsufficiency, was found in one woman; and deletion c.419–421 delACA (p.140 delN) was found in one. Functional analyses by the yeast two-hybrid assay demonstrated that the p.140 delN mutation disrupted FIGLA binding to the TCF3 helix-loop-helix (HLH) domain. Our findings show that a subset of Chinese women with sporadic, premature ovarian failure harbor mutations in FIGLA. Premature Ovarian Failure (POF [MIM 311360]) is defined as a primary ovarian defect characterized by premature depletion of ovarian follicles before the age of 40 years.1Simpson J.L. Rajkovic A. Ovarian differentiation and gonadal failure.Am. J. Med. Genet. 1999; 89: 186-200Crossref PubMed Scopus (194) Google Scholar POF has an estimated prevalence of one in 10,000 women by age 20, one in 1000 women by age 30, and one in 100 women by age 40.2Coulam C.B. Adamson S.C. Annegers J.F. Incidence of premature ovarian failure.Obstet. Gynecol. 1986; 67: 604-606PubMed Google Scholar Premature ovarian failure can be heritable, but few mechanisms have been identified.3Conway G.S. Kaltsas G. Patel A. Davies M.C. Jacobs H.S. Characterization of idiopathic premature ovarian failure.Fertil. Steril. 1996; 64: 337-341Google Scholar, 4Cramer D.W. Xu H. Harlow B.L. Family history as a predictor of early menopause.Fertil. Steril. 1995; 64: 740-745PubMed Scopus (189) Google Scholar, 5Beck-Peccoz P. Persani L. Premature ovarian failure.Orphanet J. Rare Dis. 2006; 1: 9-14Crossref PubMed Scopus (220) Google Scholar Known nongenetic mechanisms include gonadotoxic chemotherapy, radiation treatment, and autoimmune oophoritis, but in most cases POF is idiopathic and probably genetic.6Suzumori N. Pangas S.A. Rajkovic A. Candidate genes for premature ovarian failure.Curr. Med. Chem. 2007; 14: 353-357Crossref PubMed Scopus (42) Google Scholar Besides chromosome abnormalities involving X or autosomes,7Toniolo D. Rizzolio F. X chromosome and ovarian failure.Semin. Reprod. Med. 2007; 25: 264-271Crossref PubMed Scopus (42) Google Scholar single-gene-mutation associations with POF include fragile X mental retardation 1 (FMR1 [MIM 309550]),8Terracciano A. Chiurazzi P. Neri G. Fragile X syndrome.Am. J. Med. Genet. C. Semin. Med. Genet. 2005; 137: 32-37Crossref Scopus (55) Google Scholar, 9Pietrobono R. Tabolacci E. Zalfa F. Zito I. Terracciano A. Moscato U. Bagni C. Oostra B. Chiurazzi P. Neri G. Molecular dissection of the events leading to inactivation of the FMR1 gene.Hum. Mol. Genet. 2005; 14: 267-277Crossref PubMed Scopus (101) Google Scholar, 10Sullivan A.K. Marcus M. Epstein M.P. Allen E.G. Anido A.E. Paquin J.J. Yadav-Shah M. Sherman S.L. Association of FMR1 repeat size with ovarian dysfunction.Hum. Reprod. 2005; 20: 402-412Crossref PubMed Scopus (337) Google Scholar, 11Bodega B. Bione S. Dalpra L. Toniolo D. Ornaghi F. Vegetti W. Ginelli E. Marozzi A. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation.Hum. Reprod. 2006; 21: 952-957Crossref PubMed Scopus (150) Google Scholar, 12Hagerman P.J. Hagerman R.J. The fragile-X premutation: a maturing perspective.Am. J. Hum. Genet. 2004; 74: 805-816Abstract Full Text Full Text PDF PubMed Scopus (422) Google Scholar forkhead box L2 (FOXL2[MIM 605597]),13Schmidt D. Ovitt C.E. Anlag K. Fehsenfeld S. Gredsted L. Treier A.C. Treier M. The murine wingedhelix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance.Development. 2004; 131: 933-942Crossref PubMed Scopus (524) Google Scholar, 14Uda M. Ottolenghi C. Crisponi L. Garcia J.E. Deiana M. Kimber W. Forabosco A. Cao A. Schlessinger D. Pilia G. FOXL2 disruption causes mouse ovarian failure by pervasive blockage of follicle development.Hum. Mol. Genet. 2004; 13: 1171-1181Crossref PubMed Scopus (389) Google Scholar, 15Fokkema I.F. den Dunnen J.T. Taschner P.E. LOVD: easy creation of a locus-specific sequence variation database using an “LSDB-in-a-box” approach.Hum. Mutat. 2005; 26: 63-68Crossref PubMed Scopus (209) Google Scholar premature ovarian failure 1B (POF1B [MIM 300603]),16Bione S. Rizzolio F. Sala C. Ricotti R. Goegan M. Manzini M.C. Battaglia R. Marozzi A. Vegetti W. Dalprà L. et al.Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B.Hum. Reprod. 2004; 19: 2759-2766Crossref PubMed Scopus (68) Google Scholar, 17Lacombe A. Lee H. Zahed L. Choucair M. Muller J.M. Nelson S.F. Salameh W. Vilain E. Disruption of POF1B binding to nonmuscle actin filaments is associated with premature ovarian failure.Am. J. Hum. Genet. 2006; 79: 113-119Abstract Full Text Full Text PDF PubMed Scopus (83) Google Scholar inhibin alpha (INHA [MIM 147380]),18Shelling A.N. Burton K.A. Chand A.L. van Ee C.C. France J.T. Farquhar C.M. Milsom S.R. Love D.R. Gersak K. Aittomäki K. et al.Inhibin: a candidate gene for premature ovarian failure.Hum. Reprod. 2000; 15: 2644-2649Crossref PubMed Scopus (144) Google Scholar, 19Woad K.J. Watkins W.J. Prendergast D. Shelling A.N. The genetic basis of premature ovarian failure.Aust. N. Z. J. Obstet. Gynaecol. 2006; 46: 242-244Crossref PubMed Scopus (78) Google Scholar, 20Groome N.P. Illingworth P.J. O'Brien M. Cooke I. Ganesan T.S. Baird D.T., McNeilly A.S. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay.Clin. Endocrinol. (Oxf.). 1994; 40: 717-723Crossref PubMed Scopus (383) Google Scholar, 21Groome N.P. Illingworth P.J. O'Brien M. Pai R. Rodger F.E. Mather J.P., McNeilly A.S. Measurement of dimeric inhibin B throughout the human menstrual cycle.J. Clin. Endocrinol. Metab. 1996; 81: 1401-1405Crossref PubMed Scopus (832) Google Scholar, 22Marozzi A. Porta C. Vegetti W. Crosignani P.G. Tibiletti M.G. Dalpra L. Ginelli E. Mutation analysis of the inhibin alpha gene in a cohort of Italian women affected by ovarian failure.Hum. Reprod. 2002; 17: 1741-1745Crossref PubMed Scopus (90) Google Scholar, 23Dixit H. Rao K.L. Padmalatha V. Kanakavalli M. Deenadayal M. Gupta N. Chakravarty B.N. Singh L. Expansion of the germline analysis for the INHA gene in Indian women with ovarian failure.Hum. Reprod. 2006; 21: 1643-1644Crossref PubMed Scopus (22) Google Scholar NOBOX oogenesis homeobox (NOBOX [MIM 610934],24Qin Y. Choi Y. Zhao H. Simpson J.L. Chen Z.J. Rajkovic A. NOBOX homeobox mutation causes premature ovarian failure.Am. J. Hum. Genet. 2007; 81: 576-581Abstract Full Text Full Text PDF PubMed Scopus (177) Google Scholar growth differentiation factor 9 (GDF9 [MIM 601918]), and bone morphogenetic protein 15 (BMP15 [MIM 300247]).25Laissue P. Christin-Maitre S. Touraine P. Kuttenn F. Ritvos O. Aittomaki K. Bourcigaux N. Jacquesson L. Bouchard P. Frydman R. et al.Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure.Eur. J. Endocrinol. 2006; 154: 739-744Crossref PubMed Scopus (198) Google Scholar, 26Dixit H. Rao L.K. Padmalatha V. Kanakavalli M. Deenadayal M. Gupta N. Chakravarty B. Singh L. Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure.Menopause. 2005; 12: 749-754Crossref PubMed Scopus (119) Google Scholar, 27Chand A.L. Ponnampalam A.P. Harris S.E. Winship I.M. Shelling A.N. Mutational analysis of BMP15 and GDF9 as candidate genes for premature ovarian failure.Fertil. Steril. 2006; 86: 1009-1012Abstract Full Text Full Text PDF PubMed Scopus (65) Google Scholar, 28Kovanci E. Rohozinski J. Simpson J.L. Heard M.J. Bishop C.E. Carson S.A. Growth differentiating factor-9(GDF9) mutations may be associated with premature ovarian failure (POF).Fertil. Steril. 2007; 87: 143-146Abstract Full Text Full Text PDF PubMed Scopus (106) Google Scholar, 29Zhao H. Qin Y. Kovanci E. Simpson J.L. Chen Z.J. Rajkovic A. Analyses of GDF9 mutation in 100 Chinese women with premature ovarian failure.Fertil. Steril. 2007; 88: 1474-1476Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar, 30Di Pasquale E. Beck-Peccoz P. Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene.Am. J. Hum. Genet. 2004; 75: 106-111Abstract Full Text Full Text PDF PubMed Scopus (362) Google ScholarFMR1 premutation carriers have a 15% risk of developing POF, whereas the prevalence of FMR1 premutation among women with sporadic POF is less than 10%.31Wittenberger M.D. Hagerman R.J. Sherman S.L. McConkie-Rosell A. Welt C.K. Rebar R.W. Corrigan E.C. Simpson J.L. Nelson L.M. The FMR1 premutation and reproduction.Fertil. Steril. 2007; 87: 456-465Abstract Full Text Full Text PDF PubMed Scopus (292) Google Scholar The prevalence of other gene mutations in women with POF is not well known. Mouse models32Aittomäki K. Lucena J.L. Pakarinen P. Sistonen P. Tapanainen J. Gromoll J. Kaskikari R. Sankila E.M. Lehväslaiho H. Engel A.R. et al.Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure.Cell. 1995; 82: 959-968Abstract Full Text PDF PubMed Scopus (777) Google Scholar, 33Jiang M. Aittomäki K. Nilsson C. Pakarinen P. Iitiä A. Torresani T. Simonsen H. Goh V. Pettersson K. de la Chapelle A. et al.The frequency of an inactivating point mutation (566C→T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry.J. Clin. Endocrinol. Metab. 1998; 83: 4338-4343Crossref PubMed Scopus (69) Google Scholar, 34Dierich A. Sairam M.R. Monaco L. Fimia G.M. Gansmuller A. LeMeur M. Sassone-Corsi P. Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance.Proc. Natl. Acad. Sci. USA. 1998; 95: 13612-13617Crossref PubMed Scopus (664) Google Scholar, 35Kumar T.R. Wang Y. Lu N. Matzuk M.M. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility.Nat. Genet. 1997; 15: 201-204Crossref PubMed Scopus (1021) Google Scholar, 36Soyal S.M. Amleh A. Dean J. FIGalpha, a germ cell-specific transcription factor required for ovarian follicle formation.Development. 2000; 127: 4645-4654PubMed Google Scholar, 37Liang L. Soyal S.M. Dean J. FIGalpha, a germ cell specific transcription factor involved in the coordinate expression of the zona pellucida genes.Development. 1997; 124: 4939-4947PubMed Google Scholar of ovarian failure closely mimic human ovarian failure, as exemplified by mutations in the human and mouse follicle-stimulating hormone (FSH) receptor (FSHR [MIM 136435]).32Aittomäki K. Lucena J.L. Pakarinen P. Sistonen P. Tapanainen J. Gromoll J. Kaskikari R. Sankila E.M. Lehväslaiho H. Engel A.R. et al.Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure.Cell. 1995; 82: 959-968Abstract Full Text PDF PubMed Scopus (777) Google Scholar, 33Jiang M. Aittomäki K. Nilsson C. Pakarinen P. Iitiä A. Torresani T. Simonsen H. Goh V. Pettersson K. de la Chapelle A. et al.The frequency of an inactivating point mutation (566C→T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry.J. Clin. Endocrinol. Metab. 1998; 83: 4338-4343Crossref PubMed Scopus (69) Google Scholar, 34Dierich A. Sairam M.R. Monaco L. Fimia G.M. Gansmuller A. LeMeur M. Sassone-Corsi P. Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance.Proc. Natl. Acad. Sci. USA. 1998; 95: 13612-13617Crossref PubMed Scopus (664) Google Scholar, 35Kumar T.R. Wang Y. Lu N. Matzuk M.M. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility.Nat. Genet. 1997; 15: 201-204Crossref PubMed Scopus (1021) Google Scholar Targeted deletion of mouse genes indicates that there are more than 200 genes that can cause reproductive dysfunction.38Matzuk M.M. Lamb D.J. Genetic dissection of mammalian fertility pathways.Nat. Cell Biol. 2002; 4: s41-s49PubMed Google Scholar Factor in germline alpha (FIGLA [MIM 608697]), located on human chromosome 2p13.3, is a germ cell-specific basic helix-loop-helix (bHLH) transcription factor that regulates expression of zona pellucida genes as well as that of other oocyte-specific genes.37Liang L. Soyal S.M. Dean J. FIGalpha, a germ cell specific transcription factor involved in the coordinate expression of the zona pellucida genes.Development. 1997; 124: 4939-4947PubMed Google Scholar, 39Huntriss J. Gosden R. Hinkins M. Oliver B. Miller D. Rutherford A.J. Picton H.M. Isolation, characterization and expression of the human Factor In the Germline alpha (FIGLA) gene in ovarian follicles and oocytes.Mol. Hum. Reprod. 2002; 8: 1087-1095Crossref PubMed Scopus (62) Google Scholar, 40Bayne R.A. Martins da Silva S.J. Anderson R.A. Increased expression of the FIGLA transcription factor is associated with primordial follicle formation in the human fetal ovary.Mol. Hum. Reprod. 2004; 10: 373-381Crossref PubMed Scopus (62) Google Scholar bHLH proteins are a group of highly conserved transcription factors that typically bind to a consensus sequence (CANNTG), called an E-box, to promote selective genes.41Littlewood T.D. Evan G.I. Transcription factors 2: helix-loop-helix.Protein Profile. 1995; 2: 621-702PubMed Google Scholar, 42Athanikar J.N. Osborne T.F. Specificity in cholesterol regulation of gene expression by coevolution of sterol regulatory DNA element and its binding protein.Proc. Natl. Acad. Sci. USA. 1998; 95: 4935-4940Crossref PubMed Scopus (50) Google Scholar In both mouse and human, FIGLA is expressed in the embryonic gonad, heterodimerizes with ubiquitously expressed bHLH protein TCF3 (transcription factor 3 [MIM 147141]), and binds to the zona pellucida gene promoters.37Liang L. Soyal S.M. Dean J. FIGalpha, a germ cell specific transcription factor involved in the coordinate expression of the zona pellucida genes.Development. 1997; 124: 4939-4947PubMed Google Scholar, 40Bayne R.A. Martins da Silva S.J. Anderson R.A. Increased expression of the FIGLA transcription factor is associated with primordial follicle formation in the human fetal ovary.Mol. Hum. Reprod. 2004; 10: 373-381Crossref PubMed Scopus (62) Google ScholarFigla knockout mice cannot form primordial follicles and lose oocytes rapidly after birth, whereas male gonads are unaffected.36Soyal S.M. Amleh A. Dean J. FIGalpha, a germ cell-specific transcription factor required for ovarian follicle formation.Development. 2000; 127: 4645-4654PubMed Google Scholar The ovarian-failure phenotype in mice makes FIGLA a candidate gene for premature ovarian failure in humans. We therefore examined whether mutations in FIGLA are present in women with premature ovarian failure, specifically a Han Chinese cohort, compared with an ethnically matched control cohort. In this study, 100 Chinese women with POF were recruited from the Reproductive Medical Center, Shandong Provincial Hospital Affiliated to Shandong University in Jinan, Shandong, China. Controls were healthy women chosen randomly between 30 and 62 years of age, with regular menstrual cycles and no known history of infertility. Institutional review boards at both Shandong Provincial Hospital and Baylor College of Medicine approved the study. Written informed consent was obtained from all participants. Inclusion criteria were defined as cessation of menstrual cycles before 40 years of age,43Goswami D. Conway G.S. Premature ovarian failure.Hum. Reprod. Update. 2005; 11: 391-410Crossref PubMed Scopus (413) Google Scholar two serum FSH concentrations greater than 40 IU/L, and normal 46, XX karyotype. Women with associated endocrinopathies or autoimmune disorders were also excluded. Genomic DNA was extracted from blood samples, and the five exons coding for FIGLA (GeneBank accession number NM_001004311 ) were amplified with polymerase chain reaction (PCR) with four pairs of FIGLA-specific primers (Table S1, available online). Sequencing was performed via ABI Prism Sequencer 3130XL (Applied Biosystems) as previously described.44Yatsenko A.N. Roy A. Chen R. Ma L. Murthy L.J. Yan W. Lamb D.J. Matzuk M.M. Non-invasive genetic diagnosis of male infertility using spermatozoal RNA: KLHL10 mutations in oligozoospermic patients impair homodimerization.Hum. Mol. Genet. 2006; 15: 3411-3419Crossref PubMed Scopus (89) Google Scholar The PCR products were sequenced with BigDye Sequencing reagent V3.1 (Applied Biosystems). PCR and sequencing products were purified with the use of Performa Ultra 96-well PCR plates (Edge Biosystems). Sequence analyses were performed with Sequencher 4.2 software (Gene Codes). Among the 100 Chinese POF subjects, we identified in the FIGLA gene two single-nucleotide polymorphisms (SNPs), c.422C → G and c.552A → C, in both controls and POF subjects. These polymorphisms have already been reported in the online dbSNP database (dbSNP accession numbers rs7566476 and rs7566541, respectively) and did not show a statistically significant difference between controls and women with POF. We also detected three novel heterozygous variants in four individuals (Table 1): c.11C → A (p.A4E), c.15–36 del (p. G6fsX66), and c.419–421 del ACA (p.140 delN), which have been deposited into the dbSNP database. The c.11C → A changes alanine for glutamic acid and was present in two individuals with POF (S8 and S58; details are provided in Table 2) but was also present in one of the 304 control subjects. The c.11C → A thus probably represents a rare polymorphism. However, c.15–36 del and c.419–421 delACA mutations were detected only in women with POF and in none of the 304 controls.Table 1FIGLA Mutations in 100 Han Chinese Women with POFdbSNP IDExonSequence VariationAmino Acid VariationFrequency (POF)Frequency (Controls)ss993070221c.11C → Ap.Ala4Glu2/1001/304ss993070231c. 15–36 delp.G6fsX661/1000/304rs75664763c.422C → Gp.Ser141Thr12/10035/304rs75665413c.552A → GSilent12/10035/304ss993070243c.419–21 delACAp.140 delAsn1/1000/304POF = Premature Ovarian Failure; FIGLA = Factor in the Germline alpha. Open table in a new tab Table 2Phenotype of Women with POF Carrying FIGLA MutationsPatientVariantAge∗Age at exposure. (yrs)KaryotypeFSH (IU/L)LH (IU/L)E2 (pg/ml)Additional InformationS8p.Ala4Glu2246,XX70.0aSerum levels; initial value.; 78.5bSerum levels; repeat value.19.5aSerum levels; initial value.; 24.7bSerum levels; repeat value.44.2aSerum levels; initial value.; 31.8bSerum levels; repeat value.Perimenopausal syndrome; TV-B: Streak left ovary; right ovary not visualizedS13p.G6fsX663646,XX48.1aSerum levels; initial value.; 50.6bSerum levels; repeat value.32.1aSerum levels; initial value.; 11.5bSerum levels; repeat value.28.0aSerum levels; initial value.; 22.0bSerum levels; repeat value.Perimenopausal syndrome; TV-B: Ovaries not visualizedS58p.Ala4Glu3246,XX95.7aSerum levels; initial value.; 135.7bSerum levels; repeat value.42.9aSerum levels; initial value.; 47.1bSerum levels; repeat value.42.0aSerum levels; initial value.; 27.3bSerum levels; repeat value.TV-B: Small uterus and bilateral streak ovariesS69p.140 delAsn2746,XX70.4aSerum levels; initial value.; 89.6bSerum levels; repeat value.28.8aSerum levels; initial value.; 45.2bSerum levels; repeat value.17.0aSerum levels; initial value.; 11.2bSerum levels; repeat value.TV-B: Small uterus and small right ovary devoid of follicles; left ovary not visualizedFIGLA denotes factor in the germline alpha; FSH denotes follicle-stimulating hormone; LH denotes luteinizing hormone; E2 denotes estradiol; TV-B denotes Transvaginal ultrasonography.∗ Age at exposure.a Serum levels; initial value.b Serum levels; repeat value. Open table in a new tab POF = Premature Ovarian Failure; FIGLA = Factor in the Germline alpha. FIGLA denotes factor in the germline alpha; FSH denotes follicle-stimulating hormone; LH denotes luteinizing hormone; E2 denotes estradiol; TV-B denotes Transvaginal ultrasonography. The 22 base pair (22 bp) deletion, c.15–36 del (p.G6fsX66) in case S13 (Figure 1), is predicted to cause a frame shift at the 6th codon and change glycine to arginine to create a new open-reading frame ending in a stop codon at position 66 (G6fsX66).This effectively creates FIGLA haploinsufficiency. wild-type (WT) FIGLA encodes 219 amino acids, whereas truncated FIGLA protein shares only a five-amino-acid homology with the wild-type. The c.15–36 delta was not found among the entire 304 control cohort. The deleted nucleic acids are flanked by identical nine-nucleotide-long repeats (CCCCGCGCC). We hypothesize that misalignment between the first and the second repeat during recombination causes the 22bp deletion. S13 presented with secondary amenorrhea at 36 years of age (Table 2). Menarche occurred when she was 14 years old, and her subsequent menstrual cycles were irregular. At 23 years of age, she gave birth to a girl who is now healthy at the age of 16 years. S13 presented with hot flashes, excessive sweating, lassitude, emotional lability, and vaginal dryness. Her initial FSH concentration was 48.1 IU/L, and a subsequent concentration was 50.6 IU/L. Pelvic ultrasonography showed a small uterus (55×35×30 mm) and bilateral-streak ovaries devoid of follicles. The proband's 15–36 del mutation was inherited from her father, who has no evident somatic anomalies. S13's mother and daughter do not carry the deletion and have no reproductive or menstrual dysfunction. The c.419–421 delACA variant (p.140 delN) causes a loss in asparagine at position 140 (Figure 2). The proband (S69) was a 29-year-old woman presenting with secondary amenorrhea and infertility. Menarche occurred when she was 14 years old, and menstrual cycles were normal until 27 years of age, at which time secondary amenorrhea ensued. FSH concentrations were highly elevated on two separate interval measurements, at 70.4IU/L and 89.6IU/L, respectively. Transvaginal ultrasonography showed a small uterus (45 × 35 mm), an atrophic endometrium, and a small right ovary (12 × 10 mm) devoid of follicles. The left ovary was not visualized. She had no other medical problems and lacked dysmorphic features. Her parents are healthy; no other family members had POF. FIGLA is known to heterodimerize with TCF3.37Liang L. Soyal S.M. Dean J. FIGalpha, a germ cell specific transcription factor involved in the coordinate expression of the zona pellucida genes.Development. 1997; 124: 4939-4947PubMed Google Scholar, 40Bayne R.A. Martins da Silva S.J. Anderson R.A. Increased expression of the FIGLA transcription factor is associated with primordial follicle formation in the human fetal ovary.Mol. Hum. Reprod. 2004; 10: 373-381Crossref PubMed Scopus (62) Google Scholar We tested whether the missense or deleted (c.11C → A or c.419–421 delACA) alleles affect the ability of FIGLA to dimerize with itself or TCF3 by utilizing a yeast two-hybrid strategy to study protein-protein interactions. Proteins under study were either fused to GAL4 DNA-binding domain as a bait or fused to GAL4-activation domain as a prey. If bait and prey interact physically when brought together in a yeast reporter strain, GAL4 promoter-driven reporter genes (LacZ, ADE2, HIS3, and MEL1) will be transcribed, thus resulting in blue colonies on synthetic droupout (SD) plates selective for −Ade, −His, −Leu, −Trp, and X-a-gal (Figure 3A). In this study, full-length wild-type human FIGLA cDNA was purchased from ATCC (Manassas, VA, USA), and TCF3 cDNA was a gift from Rosemary A.L. Bayne (Centre for Reproductive Biology, University of Edinburgh, Edinburgh, UK40Bayne R.A. Martins da Silva S.J. Anderson R.A. Increased expression of the FIGLA transcription factor is associated with primordial follicle formation in the human fetal ovary.Mol. Hum. Reprod. 2004; 10: 373-381Crossref PubMed Scopus (62) Google Scholar). FIGLA and TCF3 (Ensembl accession number ENSG00000071564) constructs were subcloned into the MatchMaker GAL4 two-hybrid pGBKT7 and pGADT7 vectors (Clontech), and primer sequences are shown in Table S1. Mutant constructs carrying c.11C → A and c.419–421 delACA were created with the Quik-Change multi-site-directed mutagenesis kit (Stratagene) according to the manufacturer's instructions. We studied protein-protein interactions by transforming the Y187 yeast strain with mutant (11C → A and 419–421 del) and wild-type FIGLA constructs subcloned into the bait vector (pGBKT7) as previously described.44Yatsenko A.N. Roy A. Chen R. Ma L. Murthy L.J. Yan W. Lamb D.J. Matzuk M.M. Non-invasive genetic diagnosis of male infertility using spermatozoal RNA: KLHL10 mutations in oligozoospermic patients impair homodimerization.Hum. Mol. Genet. 2006; 15: 3411-3419Crossref PubMed Scopus (89) Google Scholar The corresponding prey (pGADT7) vectors containing wild-type FIGLA, FIGLA HLH domain, or TCF3 HLH domain were transformed into the AH109 yeast strain. Y187 and AH109 cells transformed with the bait and prey constructs were selected on SD plates lacking either tryptophan (SD/−Trp) or leucine (SD/−Leu), respectively, and the two strains were mated according to the manufacturer's instructions. Mating mixtures were spread onto double-dropout plates (SD[−Leu/−Trp]) for the growing of diploids. Diploid strains were streaked onto quadruple-dropout plates (SD[−Ade/−His/−Leu/−Trp/X-a-gal]), and positive interactions scored as blue colonies. Each experiment was performed in three replicates. In this study, SV40 T antigen with p53 and SV40 T antigen with Lamin C were used as positive and negative controls, respectively. We mated human wild-type FIGLA with itself or with TCF3 HLH domain containing prey constructs. Blue colonies grew on selective plates only by the mating of yeast bait wild-type (WT) FIGLA (full-length or HLH domain) with prey TCF3 HLH domain, indicating that human FIGLA can heterodimerize with TCF3 HLH domain but does not homodimerize with itself. We also studied whether TCF3 HLH domain can interact with FIGLA mutant proteins A4E and 140 delN. As shown in Figure 3B, blue colonies were detected within three days when TCF3 HLH domain was mated with WT FIGLA or FIGLA mutant A4E, but only a few white colonies appeared when it was mated with FIGLA HLH mutant 140 delN despite equivalent amounts of mutant and WT FIGLA protein (Figure 3C). We verified the two-hybrid interactions with an oxygen-biosensor assay. In three independent experiments, we measured the fluorescence emitted by the O2-sensing platform that detects GAL4. The amount of fluorescence intensity increases according to the strength of the two-hybrid interactions.45Morris J.A. Kandpal G. Ma L. Austin C.P. Dros. Inf. Serv.C1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation.Hum. Mol. Genet. 2003; 12: 1591-1608Crossref PubMed Scopus (322) Google Scholar With this method used, TCF3 HLH domain showed strong interaction with the WT FIGLA, as well as with mutant FIGLA A4E protein. Mutant FIGLA 140 delN protein showed markedly decreased interaction with the TCF3 HLH domain (p < 0.001; ANOVA) (Figure 3D). The data imply that the mutant protein FIGLA140 delN disrupts heterodimer formation between FIGLA and TCF3 whereas A4E missense mutation does not have appreciable effect on the FIGLA and TCF3 interaction in vitro. In this study, we identified two plausible mutations in the FIGLA gene among 100 POF cases (2%), whereas none were present among 304 ethnically matched controls. FIGLA is a germ cell-specific transcription factor preferentially expressed in oocytes and critical in oocyte differentiation. Transgenic mouse models replicate known human reproductive phenotypes well, as exemplified by FSH-receptor mutations.32Aittomäki K. Lucena J.L. Pakarinen P. Sistonen P. Tapanainen J. Gromoll J. Kaskikari R. Sankila E.M. Lehväslaiho H. Engel A.R. et al.Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure.Cell. 1995; 82: 959-968Abstract Full Text PDF PubMed Scopus (777) Google Scholar, 33Jiang M. Aittomäki K. Nilsson C. Pakarinen P. Iitiä A. Torresani T. Simonsen H. Goh V. Pettersson K. de la Chapelle A. et al.The frequency of an inactivating point mutation (566C→T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry.J. Clin. Endocrinol. Metab. 1998; 83: 4338-4343Crossref PubMed Scopus (69) Google Scholar, 34Dierich A. Sairam M.R. Monaco L. Fimia G.M. Gansmuller A. LeMeur M. Sassone-Corsi P. Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance.Proc. Natl. Acad. Sci. USA. 1998; 95: 13612-13617Crossref PubMed Scopus (664) Google Scholar, 35Kumar T.R. Wang Y. Lu N. Matzuk M.M. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility.Nat. Genet. 1997; 15: 201-204Crossref PubMed Scopus (1021) Google Scholar Mice completely lacking Figla expression lose oocytes rapidly after birth, are infertile, and do not display any other anatomic abnormality or dysmorphology.36Soyal S.M. Amleh A. Dean J. FIGalpha, a germ cell-specific transcription factor required for ovarian follicle formation.Development. 2000; 127: 4645-4654PubMed Google Scholar These mice thus represent a good model for the study of nonsyndromic ovarian failure. Our results, as well as supporting data from studies performed with mice, indicate that FIGLA mutations contribute to human POF. Given the heterozygous nature of mutations we report here, we cannot rule out the possibility that other genes and/or environmental factors modulate the effects of these mutations on ovarian function. One of the two heterozygous mutations we detected, G6fsX66, is predicted to prematurely terminate translation of the FIGLA transcript after five amino acids. Transcription-factor haploinsufficiency is a well-recognized cause of many human genetic syndromes.46Seidman J.G. Seidman C. Transcription factor haploinsufficiency: when half a loaf is not enough.J. Clin. Invest. 2002; 109: 451-455Crossref PubMed Scopus (156) Google Scholar Most mice heterozygous for transcription-factor mutations have no discernable phenotype, and only a homozygous transcription-factor mutation leads to pathology in mice.46Seidman J.G. Seidman C. Transcription factor haploinsufficiency: when half a loaf is not enough.J. Clin. Invest. 2002; 109: 451-455Crossref PubMed Scopus (156) Google Scholar Detailed characterization of oocyte numbers in adult Figla mice is lacking, but given what is known about other mouse models of transcription-factor insufficiency, we postulate that FIGLA haploinsufficiency in humans causes premature ovarian failure by disrupting formation of primordial follicles, as observed in Figla mouse knockouts, resulting in diminished follicular endowment and accelerated oocyte loss throughout the reproductive lifespan. We cannot exclude the possibility that the new protein created by the G6fsX66 mutation adversely affects WT FIGLA function via dominant negative interaction. The 140 delN mutation was also not present in the control cohort of women, and yeast two-hybrid analysis shows adverse effects of this mutation on FIGLA interaction with TCF3. Abnormal FIGLA function could be due to dominant negative interference of the 140 delN protein on the binding of WT FIGLA to TCF3, or it could be due to decreased levels of functional heterodimers.44Yatsenko A.N. Roy A. Chen R. Ma L. Murthy L.J. Yan W. Lamb D.J. Matzuk M.M. Non-invasive genetic diagnosis of male infertility using spermatozoal RNA: KLHL10 mutations in oligozoospermic patients impair homodimerization.Hum. Mol. Genet. 2006; 15: 3411-3419Crossref PubMed Scopus (89) Google Scholar The interaction between TCF3 and other bHLH transcription regulators occurs mainly via the bHLH domain; however, our study shows that residues outside of the bHLH domain are also important for the interaction of FIGLA with TCF3. The deleted asparagine is carboxy terminal to the bHLH domain. Residues carboxy terminal to the bHLH domain have been shown to affect heterodimerization.47Jones S. An overview of the basic helix-loop-helix proteins.Genome Biol. 2004; 5: 226Crossref PubMed Scopus (269) Google Scholar To our knowledge, this is the first study to evaluate mutations in the FIGLA gene in women with premature ovarian failure. We identified two plausible mutations in FIGLA among 100 Chinese POF subjects. Our study shows that FIGLA mutations contribute to the pathophysiology of ovarian failure and adds to the growing evidence that disruption of germ cell-specific pathways adversely affects oocyte survival in humans. Future studies should focus comprehensively on germ cell-specific pathways as contributors to the etiology of POF. We thank Junhao Yan and Junli Zhao of the Center for Reproductive Medicine (Shandong Provincial Hospital Affiliated to Shandong University, China) for their contributions during patient and control recruitment; Lang Ma, Angshumoy Roy, Alexander N. Yatsenko, and Shujuan Pan of the Department of Pathology (Baylor College of Medicine, Houston, TX, USA) for technical advice and help; and all the patients who participated in this study. This study was supported in part by National Institutes of Health grants HD44858 and HD058125 and a March of Dimes grant 6-FY05-70 to A.R., as well as by grants from the National Natural Science Foundation of the People's Republic of China (30470703 and 30670777) and the National Basic Research Program of China “973 Program” (2006CB944004) to Z-J.C. Download .pdf (.01 MB) Help with pdf files Document S1. One Table The URLs for data presented herein are as follows:GenBank, http://www.ncbi.nlm.nih.gov/Genbank/Ensembl Genome Browser, http://www.ensembl.org/Homo_Sapiens/ExPASy Proteomics Server, http://us.expasy.org/Single nucleotide polymorphism database, http://www.ncbi.nlm.nih.gov/SNP/Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nim.nih.gov/Omim/ The dbSNP database accession numbers for the c.11C → A (p.A4E), c.15–36 del (p. G6fsX66), and c.419–421 del ACA (p.140 delN) variant sequences reported in this paper are ss99307022, ss99307023, and ss99307024, respectively.